Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999

Abstract

Cerebral X-linked adrenoleukodystrophy (X-ALD) is a disorder of very-long-chain fatty acid metabolism, adrenal insufficiency, and cerebral demyelination. Death occurs within 2 to 5 years of clinical onset without hematopoietic cell transplantation (HCT). One hundred twenty-six boys with X-ALD received HCT from 1982 to 1999. Survival, engraftment, and acute graft-versus-host disease were studied. Degree of disability associated with neurologic and neuropsychological function and cerebral demyelination were evaluated before and after HCT. Complete data were available and analyzed for 94 boys with cerebral X-ALD. The estimated 5- and 8-year survival was 56%. The leading cause of death was disease progression. Donor-derived engraftment occurred in 86% of patients. Demyelination involved parietal-occipital lobes in 90%, leading to visual and auditory processing deficits in many boys. Overall 5-year survival of 92% in patients with 0 or 1 neurologic deficits and magnetic resonance imaging (MRI) severity score less than 9 before HCT was superior to survival for all others (45%; P < .01). Baseline neurologic and neuropsychological function, degree of disability, and neuroradiologic status predicted outcomes following HCT. In this first comprehensive report of the international HCT experience for X-ALD, we conclude that boys with early-stage disease benefit from HCT, whereas boys with advanced disease may be candidates for experimental therapies.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2003-10-3402

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

5 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

The citation lists are queued

They are fetched later and appear here then.

References 31 · Cited by 374

Research works printed but not linked: 6

  1. Aubourg P, Chaussain J, Dulac O, Arthuis M. Adrenoleukodystrophy in childhood: a review of 20 cases. Arch Fr Pediatr.1982;39: 663-669.
  2. Moser H, Naidu S, Kumar A, Rosenbaum A. The adrenoleukodystrophies. Crit Rev Neurobiol.1987;3: 29-88.
  3. Krivit W, Shapiro EG, Lockman LA, et al. Recommendation for treatment of childhood cerebral form of adrenoleukodystrophy. In: Hobbs J, Riches P, eds. Correction of Certain Genetic Diseases by Transplantation 1991. London, United Kingdom: The COGENT Trust; 1992: 38-49.
  4. Shapiro E, Lockman L, Balthazor M, et al. Neuropsychological and neurological function and quality-of-life before and after bone marrow transplantation for adrenoleukodystrophy. In: Ringden O, Hobbs J, Steward C, eds. Correction of Genetic Diseases by Transplantation 1997. London, United Kingdom: The COGENT Press; 1997: 52-62.
  5. Malm G, Ringdén O, Dobeln U, et al. Treatment of adrenoleukodystrophy with bone marrow transplant. In: Ringden O, Hobbs J, Steward C, eds. Correction of Genetic Diseases by Transplantation 1997. London, United Kingdom: The CO-GENT Press; 1997: 49-51.
  6. Snedecor G, Cochran W. Statistical Methods. 8th ed. Ames, Iowa: Iowa State University Press; 1989.

Metadata

Authors
Peters, C., Charnas, L. R., Tan, Y., Ziegler, R. S., Shapiro, E. G., DeFor, T., Grewal, S. S., Orchard, P. J., Abel, S. L., Goldman, A. I., Ramsay, N. K. C., Dusenbery, K. E., Loes, D. J., Lockman, L. A., Kato, S., Aubourg, P. R., Moser, H. W., & Krivit, W.
Affiliations
Kennedy Krieger Institute (US)
Venue
Blood
Published
2004-08-01
Volume
104
Issue
3
Pages
881-888
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2168472266
Cited by
374
References
31
Citations by year
2026: 4 · 2025: 14 · 2024: 15 · 2023: 12 · 2022: 18 · 2021: 24 · 2020: 14 · 2019: 17 · 2018: 18 · 2017: 17 · 2016: 11 · 2015: 13 · 2014: 23 · 2013: 18 · 2012: 13
FWCI
10.90
Type
journal article
Language
en
Open access
closed
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01ns029099-05)
  • National Institute of Neurological Disorders and Stroke (NS 29099)
Topics
  • Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
Keywords
hematopoietic stem cell transplantation, very long chain fatty acids, brain demyelination, survival, engraftment, graft-versus-host disease, neurodisability, neuropsychological performance, disease progression, treatment outcome prediction
MeSH terms
Adrenoleukodystrophy, Cause of Death, Graft vs Host Disease, Humans, Immunosuppressive Agents, Retrospective Studies, Time Factors, Whole-Body Irradiation, Survival Analysis, Treatment Outcome, Disease Progression, Transplantation Conditioning, Stem Cell Transplantation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. https://app.cochat.ai/papers/10.1182/blood-2003-10-3402
The paper
Peters, C., Charnas, L. R., Tan, Y., Ziegler, R. S., Shapiro, E. G., DeFor, T., Grewal, S. S., Orchard, P. J., Abel, S. L., Goldman, A. I., Ramsay, N. K. C., Dusenbery, K. E., Loes, D. J., Lockman, L. A., Kato, S., Aubourg, P. R., Moser, H. W., & Krivit, W. (2004). Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood. https://doi.org/10.1182/blood-2003-10-3402

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.